Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma have?
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma has 255 citations in the OpenAlex counts ScholarIQ stores.
When was Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma published?
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma has 2020 year in the ScholarIQ index.
What is the open-access status of Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma?
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma has gold oa status in the ScholarIQ index.
What is the DOI of Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma?
The DOI for Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma is on the source record.
What is the PMID of Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma?
The PMID for Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma is on the source record.
What is the OpenAlex record for Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma?
The OpenAlex for Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma is on the source record.